Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Infusion Center Licensing topic
No spam. Unsubscribe anytime.
Board discusses new licensing for infusion center pharmacies and establishing business‑model definitions
Summary
The board discussed creating definitions for pharmacy business models and a potential new licensing program for infusion center pharmacies to better align oversight with clinical compounding and sterility practices, but made no recommendations and asked stakeholders for concrete examples of barriers to patient care.
The Board of Pharmacy considered proposals to create clearer definitions for pharmacies by business model (for example, chain community pharmacy and independent community pharmacy, as referenced in Business and Professions Code section 4001) and to explore a new licensing program for infusion center pharmacies.
Board staff noted that pharmacy law currently lacks a general definition for chain community pharmacy and cited differing approaches in other states. The committee highlighted potential benefits from definitions — improved transparency for the public and more precise regulatory application — but noted that implementing definitions may require regulatory or statutory steps.
On infusion center pharmacies, staff summarized stakeholder comments that current retail‑oriented requirements can create barriers for pharmacies that prepare infusions for administration in clinical infusion centers. Commenters said a distinct infusion‑center licensing framework could modernize oversight by focusing on clinical safety, compounding/sterility practice and patient access rather than retail labeling obligations that do not apply in infusion settings.
The committee did not take action and asked stakeholders to provide specific examples of regulatory barriers; board members indicated they intend to continue the discussion at the committee level.
